前十月97%普通股基上涨 易方达战略新兴产业股票翻倍

Group 1 - In the first ten months of the year, 943 out of 974 comparable ordinary equity funds achieved positive performance, representing a 97% success rate, with only 31 funds declining [1][3] - The top-performing funds include E Fund Strategic Emerging Industries Stock A and C, with returns of 101.22% and 100.53% respectively, benefiting from the surge in sectors like semiconductors and computing [1][2] - The E Fund Information Industry Selected Stock A and C, managed by veteran Zheng Xi, also performed well, with increases of 98.31% and 97.45%, focusing on semiconductor stocks [2][3] Group 2 - The healthcare-themed funds, such as Huaan Pharmaceutical Biotechnology Stock A and C, saw significant gains of 85.88% and 85.21%, respectively, indicating strong performance in the pharmaceutical sector [3][4] - Despite the overall market rise, only 31 ordinary equity funds reported negative returns, with the largest decline being less than 7% for funds heavily invested in traditional sectors like medicine and liquor [3][4] - The Baoying Brand Consumption Stock A and C experienced declines of 4.71% and 5.39%, attributed to a shift in management and a focus on consumer stocks [4][5] Group 3 - The data from Tonghuashun indicates that the performance of various funds is closely tied to their sector focus, with technology and healthcare leading the gains [1][3] - The report highlights the importance of fund management experience, as seen with managers like Zheng Xi and Ouyang Liangqi, who have extensive backgrounds in industry research [2][3] - The overall trend in the A-share market suggests a strong recovery, with a majority of funds benefiting from sector-specific booms, particularly in technology and healthcare [1][3]